Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line
- PMID: 1654461
- PMCID: PMC249087
- DOI: 10.1128/JVI.65.10.5641-5646.1991
Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line
Abstract
The enhancer of the human neurotropic papovavirus JC virus (JCV) restricts viral transcription to glial cells. We utilized the tissue specificity of the JCV enhancer as a tool to investigate the function of human immunodeficiency virus (HIV) Tat in transcriptional activation. The reporter plasmid pJCTAR-CAT was constructed by inserting the HIV type 1 Tat-responsive element, TAR, between the JCV promoter and the chloramphenicol acetyltransferase (CAT) gene. Cotransfection of pJCTAR-CAT and pSV-Tat, an expression vector for Tat, resulted in a 50-fold increase in JCV promoter activity in cells nonpermissive for JCV expression. Both the 98-bp JCV enhancer and the HIV TAR sequences were required for transactivation of pJCTAR-CAT in nonpermissive cells. The transactivation by Tat occurred at the level of transcription, as the increase in CAT activity paralleled an increase in the steady-state levels of CAT mRNA in S1 nuclease and nuclear run-on analyses. In the presence of Tat, the JCV enhancer is functional in cells normally nonpermissive for JCV expression; therefore, our results provide unique evidence that HIV type 1 Tat may regulate the activity of specific transcription factors.
Similar articles
-
Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.J Virol. 1992 Dec;66(12):7355-61. doi: 10.1128/JVI.66.12.7355-7361.1992. J Virol. 1992. PMID: 1331525 Free PMC article.
-
Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.Virology. 1997 Aug 18;235(1):48-64. doi: 10.1006/viro.1997.8672. Virology. 1997. PMID: 9300036
-
Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.Proc Natl Acad Sci U S A. 1990 May;87(9):3479-83. doi: 10.1073/pnas.87.9.3479. Proc Natl Acad Sci U S A. 1990. PMID: 2159152 Free PMC article.
-
Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.Oncogene. 1990 Dec;5(12):1737-42. Oncogene. 1990. PMID: 2178236
-
Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.Biochemistry. 2000 Sep 26;39(38):11532-9. doi: 10.1021/bi000708q. Biochemistry. 2000. PMID: 10995220
Cited by
-
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.J Virol. 1992 Dec;66(12):7159-67. doi: 10.1128/JVI.66.12.7159-7167.1992. J Virol. 1992. PMID: 1279199 Free PMC article.
-
Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.J Virol. 1994 Jul;68(7):4177-85. doi: 10.1128/JVI.68.7.4177-4185.1994. J Virol. 1994. PMID: 8207793 Free PMC article.
-
Human polyomavirus reactivation: disease pathogenesis and treatment approaches.Clin Dev Immunol. 2013;2013:373579. doi: 10.1155/2013/373579. Epub 2013 May 2. Clin Dev Immunol. 2013. PMID: 23737811 Free PMC article. Review.
-
Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1.Arch Virol. 1994;135(1-2):13-28. doi: 10.1007/BF01309762. Arch Virol. 1994. PMID: 7515223
-
[Progressive multifocal leukoencephalopathy].Med Klin (Munich). 1999 May 15;94(5):264-73. doi: 10.1007/BF03045050. Med Klin (Munich). 1999. PMID: 10408188 Review. German.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous